bloodstream infection in a pediatric patient with pulmonary arterial hypertension receiving intravenous treprostinil therapy

Author： Wen A.   Weiss I.   Kelly R.  

Publisher： Springer Publishing Company

ISSN： 0300-8126

Source： Infection, Vol.41, Iss.3, 2013-06, pp. : 719-722

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Use of subcutaneous treprostinil in pediatric pulmonary arterial hypertension—Bridge‐to‐transplant or long‐term treatment?

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension

By Narine L.   Hague L. K.   Walker J. H.   Vicente C.   Schilz R.   Desjardins O.   Einarson T. R.   Iskedjian M.  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 2007-2016

Informa Healthcare

Access to resources Recommend Favorite

Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial

By  

Respiration, Vol. 92, Iss. 6, 2016-10 ,pp. : 362-370

Karger

Access to resources Recommend Favorite

Combination Therapy in Pulmonary Arterial Hypertension

By  

Cardiology, Vol. 123, Iss. 1, 2012-09 ,pp. : 41-41

Karger

Access to resources Recommend Favorite

Combination Therapy in Pulmonary Arterial Hypertension: A Meta-Analysis

By  

Cardiology, Vol. 120, Iss. 3, 2011-12 ,pp. : 157-165

Karger

Access to resources Recommend Favorite